HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.4 Linux 07DEC21:22:31:4607DEC21:22:31:46 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SUPPEC SASDATA 9.4 Linux 07DEC21:22:31:4607DEC21:22:31:46 Supplemental Qualifiers for EC HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000001000000000000000000000 STUDYID Study Identifier RDOMAIN Related Domain Abbreviation USUBJID Unique Subject Identifier IDVAR Identifying Variable IDVARVALIdentifying Variable Value %QNAM Qualifier Variable Name &%QLABEL Qualifier Variable Label -^QVAL Data Value R QORIG Origin  QEVAL Evaluator HEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 C4591001ECC4591001 1005 10051317ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051317ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051317ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051317ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051317ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051317ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051317ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051317ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051317ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051317ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051328ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051328ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051328ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051328ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051328ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051328ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051328ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051328ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051328ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051328ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051339ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051339ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051339ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051339ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051339ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051339ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051339ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051339ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051339ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051339ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051339ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051339ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051339ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051410ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051410ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051410ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051410ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051410ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051410ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051410ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051410ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051410ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051410ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051410ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051410ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051410ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051412ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051412ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051412ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051412ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051412ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051412ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051412ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051412ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051412ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051412ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051413ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051413ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051413ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051413ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051413ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051413ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051413ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051413ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051413ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051413ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051414ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051414ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051414ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051414ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051414ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051414ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051414ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051414ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051414ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051414ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051414ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051414ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051414ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051415ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051415ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051415ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051415ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051415ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051415ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051415ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051415ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051415ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051415ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051415ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051415ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051415ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051417ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051417ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051417ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051417ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051417ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051417ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051417ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051417ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051417ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051417ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051417ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051417ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051417ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051418ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051418ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051418ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051418ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051418ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051418ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051418ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051418ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051418ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051418ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051419ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051419ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051419ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051419ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051419ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051419ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051419ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051419ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051419ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051419ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051419ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051419ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051419ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051420ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051420ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051420ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051420ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051420ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051420ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051420ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051420ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051420ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051420ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051421ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051421ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051421ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051421ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051421ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051421ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051421ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051421ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051421ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051421ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051421ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051421ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051421ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051422ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051422ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051422ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051422ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051422ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051422ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051422ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051422ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051422ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051422ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051422ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051422ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051422ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051424ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051424ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051424ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051424ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051424ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051424ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051424ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051424ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051424ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051424ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051425ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051425ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051425ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051425ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051425ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051425ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051425ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051425ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051425ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051425ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051427ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051427ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051427ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051427ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051427ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051427ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051427ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051427ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051427ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051427ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051427ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051427ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051427ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051428ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051428ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051428ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051428ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051428ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051428ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051428ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051428ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051428ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051428ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051429ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051429ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051429ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051429ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051429ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051429ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051429ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051429ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051429ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051429ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051430ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051430ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051430ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051430ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051430ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051430ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051430ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051430ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051430ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051430ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051430ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051430ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051430ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051431ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051431ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051431ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051431ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051431ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051431ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051431ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051431ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051431ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051431ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051436ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051436ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051436ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051436ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051436ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051436ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051436ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051436ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051436ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051436ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051437ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051437ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051437ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051437ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051437ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051437ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051437ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051437ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051437ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051437ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051437ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051437ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051437ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051438ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051438ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051438ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051438ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051438ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051438ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051438ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051438ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051438ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051438ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051438ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051438ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051438ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051439ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051439ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051439ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051439ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051439ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051439ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051439ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051439ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051439ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051439ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051440ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051440ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051440ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051440ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051440ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051440ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051440ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051440ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051440ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051440ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051440ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051440ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051440ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051441ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051441ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051441ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051441ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051441ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051441ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051441ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051441ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051441ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051441ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051444ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051444ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051444ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051444ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051444ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051444ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051444ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051444ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051444ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051444ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051444ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051444ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051444ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051445ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051445ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051445ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051445ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051445ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051445ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051445ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051445ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051445ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051445ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051445ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051445ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051445ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051447ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051447ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051447ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051447ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051447ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051447ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051447ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051447ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051447ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051447ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051448ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051448ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051448ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051448ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051448ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051448ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051448ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051448ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051448ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051448ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051448ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051448ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051448ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051449ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051449ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051449ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051449ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051449ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051449ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051449ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051449ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051449ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051449ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051450ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051450ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051450ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051450ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051450ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051450ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051450ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051450ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051450ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051450ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051450ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051450ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1005 10051450ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051451ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051451ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051451ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051451ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051451ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1005 10051451ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051451ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1005 10051451ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1005 10051451ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1005 10051451ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061183ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061183ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061183ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061183ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061183ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061183ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061183ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061183ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061183ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061183ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061183ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061183ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061183ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061184ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061184ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061184ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061184ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061184ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061184ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061184ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061184ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061184ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061184ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061188ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061188ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061188ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061188ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061188ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061188ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061188ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061188ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061188ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061188ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061188ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061188ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061188ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061189ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061189ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061189ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061189ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061189ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061189ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061189ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061189ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061189ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061189ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061190ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061190ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061190ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061190ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061190ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061190ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061190ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061190ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061190ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061190ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061191ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061191ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061191ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061191ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061191ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061191ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061191ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061191ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061191ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061191ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061196ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061196ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061196ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061196ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061196ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061196ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061196ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061196ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061196ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061196ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061196ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061196ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061196ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061200ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061200ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061200ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061200ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061200ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061200ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061200ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061200ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061200ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061200ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061200ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061200ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061200ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061201ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061201ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061201ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061201ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061201ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061201ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061201ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061201ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061201ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061201ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061203ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061203ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061203ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061203ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061203ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061203ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061203ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061203ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061203ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061203ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061206ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061206ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061206ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061206ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061206ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061206ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061206ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061206ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061206ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061206ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061207ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061207ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061207ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061207ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061207ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061207ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061207ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061207ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061207ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061207ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061209ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061209ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061209ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061209ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061209ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061209ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061209ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061209ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061209ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061209ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061212ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061212ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061212ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061212ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061212ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061212ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061212ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061212ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061212ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061212ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061212ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061212ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061212ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061213ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061213ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061213ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061213ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061213ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061213ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061213ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061213ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061213ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061213ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061214ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061214ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061214ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061214ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061214ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061214ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061214ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061214ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061214ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061214ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061214ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061214ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061214ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061219ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061219ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061219ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061219ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061219ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061219ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061219ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061219ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061219ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061219ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061219ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061219ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061219ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061220ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061220ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061220ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061220ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061220ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061220ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061220ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061220ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061220ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061220ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061221ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061221ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061221ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061221ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061221ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061221ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061221ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061221ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061221ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061221ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061223ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061223ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061223ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061223ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061223ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061223ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061223ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061223ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061223ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061223ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061223ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061223ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061223ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061224ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061224ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061224ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061224ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061224ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061224ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061224ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061224ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061224ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061224ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061226ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061226ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061226ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061226ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061226ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061226ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061226ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061226ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061226ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061226ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061226ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061226ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061226ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061227ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061227ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061227ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061227ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061227ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061227ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061227ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061227ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061227ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061227ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061228ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061228ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061228ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061228ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061228ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061228ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061228ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061228ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061228ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061228ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061228ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061228ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061228ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061229ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061229ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061229ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061229ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061229ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061229ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061229ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061229ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061229ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061229ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061229ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061229ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061229ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061230ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061230ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061230ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061230ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061230ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061230ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061230ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061230ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061230ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061230ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061231ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061231ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061231ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061231ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061231ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061231ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061231ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061231ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061231ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061231ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061232ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061232ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061232ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061232ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061232ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061232ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061232ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061232ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061232ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061232ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061232ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061232ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061232ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061233ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061233ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061233ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061233ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061233ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061233ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061233ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061233ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061233ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061233ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061233ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061233ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061233ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061234ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061234ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061234ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061234ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061234ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061234ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061234ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061234ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061234ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061234ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061235ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061235ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061235ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061235ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061235ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061235ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061235ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061235ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061235ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061235ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061235ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061235ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061235ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061236ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061236ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061236ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061236ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061236ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061236ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061236ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061236ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061236ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061236ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061237ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061237ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061237ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061237ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061237ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061237ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061237ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061237ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061237ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061237ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061237ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061237ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061237ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061239ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061239ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061239ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061239ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061239ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061239ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061239ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061239ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061239ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061239ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061239ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061239ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061239ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061241ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061241ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061241ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061241ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061241ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061241ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061241ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061241ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061241ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061241ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061242ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061242ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061242ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061242ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061242ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061242ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061242ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061242ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061242ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061242ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061243ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061243ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061243ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061243ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061243ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061243ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061243ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061243ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061243ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061243ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061244ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061244ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061244ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061244ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061244ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061244ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061244ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061244ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061244ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061244ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061245ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061245ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061245ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061245ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061245ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061245ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061245ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061245ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061245ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061245ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061245ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061245ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061245ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061247ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061247ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061247ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061247ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061247ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061247ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061247ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061247ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061247ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061247ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061247ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061247ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061247ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061248ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061248ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061248ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061248ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061248ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061248ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061248ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061248ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061248ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061248ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061248ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061248ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061248ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061249ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061249ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061249ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061249ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061249ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061249ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061249ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061249ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061249ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061249ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061250ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061250ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061250ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061250ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061250ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061250ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061250ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061250ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061250ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061250ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061250ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061250ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061250ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061252ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061252ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061252ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061252ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061252ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061252ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061252ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061252ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061252ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061252ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061253ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061253ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061253ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061253ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061253ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061253ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061253ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061253ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061253ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061253ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061253ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061253ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061253ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061254ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061254ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061254ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061254ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061254ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061254ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061254ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061254ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061254ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061254ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061256ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061256ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061256ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061256ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061256ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061256ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061256ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061256ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061256ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061256ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061257ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061257ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061257ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061257ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061257ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061257ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061257ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061257ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061257ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061257ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061257ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061257ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061257ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061258ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061258ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061258ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061258ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061258ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061258ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061258ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061258ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061258ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061258ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061259ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061259ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061259ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061259ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061259ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061259ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061259ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061259ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061259ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061259ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061259ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061259ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061259ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061260ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061260ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061260ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061260ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061260ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061260ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061260ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061260ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061260ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061260ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061260ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061260ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061260ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061261ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061261ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061261ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061261ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061261ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061261ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061261ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061261ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061261ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061261ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061262ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061262ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061262ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061262ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061262ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061262ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061262ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061262ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061262ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061262ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061262ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061262ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061262ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061263ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061263ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061263ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061263ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061263ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061263ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061263ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061263ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061263ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061263ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061264ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061264ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061264ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061264ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061264ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061264ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061264ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061264ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061264ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061264ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061265ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061265ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061265ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061265ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061265ECSEQ1ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1006 10061265ECSEQ1FDDTC Date of First Delay 2020-12-15 CRF C4591001ECC4591001 1006 10061265ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061265ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061265ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061265ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061265ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061266ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061266ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061266ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061266ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061266ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061266ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061266ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061266ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061266ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061266ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061266ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061266ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061266ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061267ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061267ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061267ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061267ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061267ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061267ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061267ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061267ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061267ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061267ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061267ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061267ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061267ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061269ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061269ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061269ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061269ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061269ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061269ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061269ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061269ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061269ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061269ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061270ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061270ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061270ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061270ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061270ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061270ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061270ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061270ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061270ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061270ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061270ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061270ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061270ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061271ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061271ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061271ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061271ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061271ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061271ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061271ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061271ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061271ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061271ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061272ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061272ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061272ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061272ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061272ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061272ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061272ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061272ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061272ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061272ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061273ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061273ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061273ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061273ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061273ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061273ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061273ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061273ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061273ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061273ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061273ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061273ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061273ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061274ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061274ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061274ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061274ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061274ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061274ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061274ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061274ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061274ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061274ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061276ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061276ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061276ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061276ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061276ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061276ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061276ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061276ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061276ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061276ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061276ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061276ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061276ECSEQ4ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1006 10061276ECSEQ4FDDTC Date of First Delay 2021-06-08 CRF C4591001ECC4591001 1006 10061277ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061277ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061277ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061277ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061277ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061277ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061277ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061277ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061277ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061277ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061277ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061277ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061277ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061278ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061278ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061278ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061278ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061278ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061278ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061278ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061278ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061278ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061278ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061279ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061279ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061279ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061279ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061279ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061279ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061279ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061279ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061279ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061279ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061279ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061279ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061279ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061280ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061280ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061280ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061280ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061280ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061280ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061280ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061280ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061280ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061280ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061282ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061282ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061282ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061282ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061282ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061282ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061282ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061282ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061282ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061282ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061283ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061283ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061283ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061283ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061283ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061283ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061283ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061283ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061283ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061283ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061283ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061283ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061283ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061284ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061284ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061284ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061284ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061284ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061284ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061284ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061284ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061284ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061284ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061284ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061284ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061284ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061285ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061285ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061285ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061285ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061285ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061285ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061285ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061285ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061285ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061285ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061285ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061285ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061285ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061286ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061286ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061286ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061286ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061286ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061286ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061286ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061286ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061286ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061286ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061287ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061287ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061287ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061287ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061287ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061287ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061287ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061287ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061287ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061287ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061288ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061288ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061288ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061288ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061288ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061288ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061288ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061288ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061288ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061288ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061289ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061289ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061289ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061289ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061289ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061289ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061289ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061289ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061289ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061289ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061290ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061290ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061290ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061290ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061290ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061290ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061290ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061290ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061290ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061290ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061291ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061291ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061291ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061291ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061291ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061291ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061291ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061291ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061291ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061291ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061291ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061291ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061291ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061292ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061292ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061292ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061292ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061292ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061292ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061292ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061292ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061292ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061292ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061292ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061292ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061292ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061293ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061293ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061293ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061293ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061293ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061293ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061293ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061293ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061293ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061293ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061294ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061294ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061294ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061294ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061294ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061294ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061294ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061294ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061294ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061294ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061294ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061294ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061294ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061295ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061295ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061295ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061295ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061295ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061295ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061295ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061295ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061295ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061295ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061295ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061295ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061295ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061296ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061296ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061296ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061296ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061296ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061296ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061296ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061296ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061296ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061296ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061297ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061297ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061297ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061297ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061297ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061297ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061297ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061297ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061297ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061297ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061298ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061298ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061298ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061298ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061298ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061298ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061298ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061298ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061298ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061298ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061298ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061298ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1006 10061298ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061299ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061299ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061299ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061299ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061299ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061299ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061299ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061299ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061299ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061299ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061300ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061300ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061300ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061300ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061300ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1006 10061300ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061300ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1006 10061300ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1006 10061300ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1006 10061300ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071409ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071409ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071409ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071409ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071409ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071409ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071409ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071409ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071409ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071409ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071414ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071414ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071414ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071414ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071414ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071414ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071414ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071414ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071414ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071414ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071414ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071414ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071414ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071415ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071415ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071415ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071415ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071415ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071415ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071415ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071415ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071415ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071415ECSEQ2ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1007 10071415ECSEQ2FDDTC Date of First Delay 2020-11-12 CRF C4591001ECC4591001 1007 10071417ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071417ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071417ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071417ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071417ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071417ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071417ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071417ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071417ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071417ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071428ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071428ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071428ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071428ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071428ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071428ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071428ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071428ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071428ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071428ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071429ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071429ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071429ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071429ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071429ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071429ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071429ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071429ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071429ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071429ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071467ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071467ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071467ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071467ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071467ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071467ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071467ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071467ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071467ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071467ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071469ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071469ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071469ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071469ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071469ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071469ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071469ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071469ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071469ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071469ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071471ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071471ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071471ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071471ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071471ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071471ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071471ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071471ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071471ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071471ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071472ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071472ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071472ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071472ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071472ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071472ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071472ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071472ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071472ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071472ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071472ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071472ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071472ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071475ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071475ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071475ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071475ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071475ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071475ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071475ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071475ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071475ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071475ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071476ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071476ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071476ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071476ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071476ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071476ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071476ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071476ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071476ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071476ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071478ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071478ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071478ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071478ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071478ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071478ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071478ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071478ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071478ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071478ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071478ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071478ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071478ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071480ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071480ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071480ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071480ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071480ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071480ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071480ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071480ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071480ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071480ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071480ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071480ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071480ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071481ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071481ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071481ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071481ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071481ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071481ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071481ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071481ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071481ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071481ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071481ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071481ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071481ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071482ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071482ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071482ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071482ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071482ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071482ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071482ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071482ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071482ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071482ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071483ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071483ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071483ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071483ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071483ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071483ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071483ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071483ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071483ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071483ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071483ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071483ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071483ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071484ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071484ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071484ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071484ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071484ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071484ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071484ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071484ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071484ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071484ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071484ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071484ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071484ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071485ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071485ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071485ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071485ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071485ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071485ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071485ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071485ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071485ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071485ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071488ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071488ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071488ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071488ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071488ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071488ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071488ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071488ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071488ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071488ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071490ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071490ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071490ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071490ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071490ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071490ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071490ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071490ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071490ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071490ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071492ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071492ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071492ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071492ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071492ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071492ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071492ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071492ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071492ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071492ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071494ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071494ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071494ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071494ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071494ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071494ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071494ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071494ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071494ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071494ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071495ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071495ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071495ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071495ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071495ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071495ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071495ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071495ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071495ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071495ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071495ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071495ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071495ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071496ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071496ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071496ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071496ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071496ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071496ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071496ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071496ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071496ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071496ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071496ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071496ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071496ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071497ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071497ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071497ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071497ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071497ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071497ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071497ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071497ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071497ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071497ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071499ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071499ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071499ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071499ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071499ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071499ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071499ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071499ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071499ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071499ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071500ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071500ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071500ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071500ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071500ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071500ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071500ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071500ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071500ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071500ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071504ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071504ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071504ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071504ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071504ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071504ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071504ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071504ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071504ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071504ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071505ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071505ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071505ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071505ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071505ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071505ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071505ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071505ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071505ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071505ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071505ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071505ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071505ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071506ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071506ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071506ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071506ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071506ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071506ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071506ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071506ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071506ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071506ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071507ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071507ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071507ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071507ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071507ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071507ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071507ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071507ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071507ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071507ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071507ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071507ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071507ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071508ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071508ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071508ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071508ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071508ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071508ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071508ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071508ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071508ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071508ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071509ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071509ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071509ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071509ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071509ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071509ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071509ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071509ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071509ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071509ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071509ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071509ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071509ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071511ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071511ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071511ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071511ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071511ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071511ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071511ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071511ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071511ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071511ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071511ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071511ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071511ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071512ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071512ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071512ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071512ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071512ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071512ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071512ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071512ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071512ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071512ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071514ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071514ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071514ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071514ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071514ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071514ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071514ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071514ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071514ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071514ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071515ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071515ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071515ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071515ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071515ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071515ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071515ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071515ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071515ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071515ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071516ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071516ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071516ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071516ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071516ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071516ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071516ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071516ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071516ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071516ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071516ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071516ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071516ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071517ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071517ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071517ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071517ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071517ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071517ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071517ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071517ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071517ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071517ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071518ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071518ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071518ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071518ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071518ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071518ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071518ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071518ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071518ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071518ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071519ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071519ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071519ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071519ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071519ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071519ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071519ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071519ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071519ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071519ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071519ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071519ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071519ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071520ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071520ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071520ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071520ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071520ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071520ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071520ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071520ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071520ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071520ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071520ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071520ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071520ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071521ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071521ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071521ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071521ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071521ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071521ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071521ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071521ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071521ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071521ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071522ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071522ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071522ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071522ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071522ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071522ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071522ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071522ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071522ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071522ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071522ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071522ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071522ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071523ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071523ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071523ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071523ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071523ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071523ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071523ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071523ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071523ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071523ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071524ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071524ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071524ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071524ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071524ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071524ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071524ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071524ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071524ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071524ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071524ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071524ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071524ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071525ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071525ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071525ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071525ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071525ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071525ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071525ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071525ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071525ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071525ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071526ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071526ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071526ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071526ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071526ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071526ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071526ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071526ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071526ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071526ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071527ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071527ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071527ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071527ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071527ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071527ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071527ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071527ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071527ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071527ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071527ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071527ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071527ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071528ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071528ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071528ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071528ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071528ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071528ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071528ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071528ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071528ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071528ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071529ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071529ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071529ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071529ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071529ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071529ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071529ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071529ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071529ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071529ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071530ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071530ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071530ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071530ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071530ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071530ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071530ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071530ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071530ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071530ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071531ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071531ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071531ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071531ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071531ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071531ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071531ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071531ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071531ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071531ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071531ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071531ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071531ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071533ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071533ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071533ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071533ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071533ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071533ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071533ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071533ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071533ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071533ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071533ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071533ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071533ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071535ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071535ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071535ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071535ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071535ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071535ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071535ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071535ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071535ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071535ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071536ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071536ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071536ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071536ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071536ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071536ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071536ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071536ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071536ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071536ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071537ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071537ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071537ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071537ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071537ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071537ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071537ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071537ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071537ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071537ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071539ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071539ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071539ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071539ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071539ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071539ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071539ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071539ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071539ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071539ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071539ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071539ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071539ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071540ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071540ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071540ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071540ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071540ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071540ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071540ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071540ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071540ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071540ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071540ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071540ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071540ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071541ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071541ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071541ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071541ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071541ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071541ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071541ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071541ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071541ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071541ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071541ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071541ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071541ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071542ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071542ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071542ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071542ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071542ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071542ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071542ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071542ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071542ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071542ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071543ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071543ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071543ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071543ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071543ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071543ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071543ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071543ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071543ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071543ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071544ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071544ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071544ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071544ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071544ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071544ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071544ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071544ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071544ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071544ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071546ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071546ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071546ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071546ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071546ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071546ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071546ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071546ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071546ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071546ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071547ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071547ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071547ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071547ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071547ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071547ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071547ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071547ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071547ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071547ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071547ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071547ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071547ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071550ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071550ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071550ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071550ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071550ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071550ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071550ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071550ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071550ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071550ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071551ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071551ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071551ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071551ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071551ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071551ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071551ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071551ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071551ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071551ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071551ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071551ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071551ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071552ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071552ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071552ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071552ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071552ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071552ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071552ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071552ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071552ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071552ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071552ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071552ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071552ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071554ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071554ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071554ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071554ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071554ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071554ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071554ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071554ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071554ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071554ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071555ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071555ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071555ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071555ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071555ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071555ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071555ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071555ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071555ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071555ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071557ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071557ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071557ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071557ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071557ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071557ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071557ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071557ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071557ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071557ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071558ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071558ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071558ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071558ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071558ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071558ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071558ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071558ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071558ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071558ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071559ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071559ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071559ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071559ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071559ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071559ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071559ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071559ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071559ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071559ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071559ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071559ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071559ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071560ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071560ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071560ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071560ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071560ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071560ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071560ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071560ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071560ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071560ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071560ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071560ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071560ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071561ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071561ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071561ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071561ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071561ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071561ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071561ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071561ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071561ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071561ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071562ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071562ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071562ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071562ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071562ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071562ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071562ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071562ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071562ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071562ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071562ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071562ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071562ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071563ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071563ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071563ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071563ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071563ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071563ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071563ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071563ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071563ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071563ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071563ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071563ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071563ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071564ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071564ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071564ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071564ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071564ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071564ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071564ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071564ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071564ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071564ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071565ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071565ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071565ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071565ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071565ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071565ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071565ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071565ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071565ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071565ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071566ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071566ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071566ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071566ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071566ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071566ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071566ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071566ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071566ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071566ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071567ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071567ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071567ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071567ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071567ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071567ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071567ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071567ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071567ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071567ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071568ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071568ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071568ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071568ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071568ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071568ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071568ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071568ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071568ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071568ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071568ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071568ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071568ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071569ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071569ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071569ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071569ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071569ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071569ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071569ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071569ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071569ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071569ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071569ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071569ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071569ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071570ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071570ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071570ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071570ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071570ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071570ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071570ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071570ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071570ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071570ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071570ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071570ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071570ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071571ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071571ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071571ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071571ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071571ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071571ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071571ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071571ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071571ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071571ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071572ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071572ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071572ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071572ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071572ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071572ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071572ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071572ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071572ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071572ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071573ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071573ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071573ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071573ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071573ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071573ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071573ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071573ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071573ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071573ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071574ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071574ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071574ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071574ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071574ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071574ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071574ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071574ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071574ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071574ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071575ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071575ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071575ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071575ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071575ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071575ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071575ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071575ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071575ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071575ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071576ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071576ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071576ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071576ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071576ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071576ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071576ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071576ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071576ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071576ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071576ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071576ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071576ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071577ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071577ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071577ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071577ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071577ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071577ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071577ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071577ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071577ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071577ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071577ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071577ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071577ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071578ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071578ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071578ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071578ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071578ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071578ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071578ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071578ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071578ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071578ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071578ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071578ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071578ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071579ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071579ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071579ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071579ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071579ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071579ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071579ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071579ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071579ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071579ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071580ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071580ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071580ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071580ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071580ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071580ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071580ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071580ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071580ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071580ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071581ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071581ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071581ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071581ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071581ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071581ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071581ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071581ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071581ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071581ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071581ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071581ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071581ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071582ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071582ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071582ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071582ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071582ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071582ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071582ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071582ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071582ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071582ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071583ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071583ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071583ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071583ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071583ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071583ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071583ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071583ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071583ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071583ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071583ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071583ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071583ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071584ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071584ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071584ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071584ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071584ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071584ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071584ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071584ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071584ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071584ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071585ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071585ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071585ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071585ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071585ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071585ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071585ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071585ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071585ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071585ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071585ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071585ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071585ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071586ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071586ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071586ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071586ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071586ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071586ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071586ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071586ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071586ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071586ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071586ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071586ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071586ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071587ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071587ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071587ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071587ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071587ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071587ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071587ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071587ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071587ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071587ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071588ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071588ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071588ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071588ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071588ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071588ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071588ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071588ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071588ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071588ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071589ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071589ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071589ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071589ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071589ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071589ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071589ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071589ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071589ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071589ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071589ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071589ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071589ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071590ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071590ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071590ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071590ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071590ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071590ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071590ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071590ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071590ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071590ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071591ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071591ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071591ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071591ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071591ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071591ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071591ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071591ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071591ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071591ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071591ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071591ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071591ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071592ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071592ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071592ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071592ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071592ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071592ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071592ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071592ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071592ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071592ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071593ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071593ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071593ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071593ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071593ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071594ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071594ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071594ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071594ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071594ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071594ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071594ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071594ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071594ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071594ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071595ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071595ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071595ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071595ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071595ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071595ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071595ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071595ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071595ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071595ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071595ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071595ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071595ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071596ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071596ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071596ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071596ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071596ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071596ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071596ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071596ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071596ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071596ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071596ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071596ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071596ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071597ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071597ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071597ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071597ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071597ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071597ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071597ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071597ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071597ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071597ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071599ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071599ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071599ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071599ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071599ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071599ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071599ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071599ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071599ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071599ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071600ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071600ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071600ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071600ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071600ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071600ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071600ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071600ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071600ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071600ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071600ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071600ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071600ECSEQ4ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1007 10071600ECSEQ4FDDTC Date of First Delay 2021-06-22 CRF C4591001ECC4591001 1007 10071601ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071601ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071601ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071601ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071601ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071601ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071601ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071601ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071601ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071601ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071602ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071602ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071602ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071602ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071602ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071602ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071602ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071602ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071602ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071602ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071603ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071603ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071603ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071603ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071603ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071603ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071603ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071603ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071603ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071603ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071604ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071604ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071604ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071604ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071604ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071604ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071604ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071604ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071604ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071604ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071605ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071605ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071605ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071605ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071605ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071605ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071605ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071605ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071605ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071605ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071606ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071606ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071606ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071606ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071606ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071606ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071606ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071606ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071606ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071606ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071607ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071607ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071607ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071607ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071607ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071607ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071607ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071607ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071607ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071607ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071607ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071607ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071607ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071608ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071608ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071608ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071608ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071608ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071608ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071608ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071608ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071608ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071608ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071608ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071608ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071608ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071609ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071609ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071609ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071609ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071609ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071609ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071609ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071609ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071609ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071609ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071610ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071610ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071610ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071610ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071610ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071610ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071610ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071610ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071610ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071610ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071612ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071612ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071612ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071612ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071612ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071612ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071612ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071612ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071612ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071612ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071613ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071613ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071613ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071613ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071613ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071613ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071613ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071613ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071613ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071613ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071613ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071613ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071613ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071614ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071614ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071614ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071614ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071614ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071614ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071614ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071614ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071614ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071614ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071614ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071614ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071614ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071615ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071615ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071615ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071615ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071615ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071615ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071615ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071615ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071615ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071615ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071616ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071616ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071616ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071616ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071616ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071616ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071616ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071616ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071616ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071616ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071617ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071617ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071617ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071617ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071617ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071617ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071617ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071617ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071617ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071617ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071617ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071617ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071617ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071618ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071618ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071618ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071618ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071618ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071618ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071618ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071618ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071618ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071618ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071619ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071619ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071619ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071619ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071619ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071619ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071619ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071619ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071619ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071619ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071620ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071620ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071620ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071620ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071620ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071620ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071620ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071620ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071620ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071620ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071621ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071621ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071621ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071621ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071621ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071621ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071621ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071621ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071621ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071621ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071622ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071622ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071622ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071622ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071622ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071623ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071623ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071623ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071623ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071623ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071623ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071623ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071623ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071623ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071623ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071623ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071623ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071623ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071624ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071624ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071624ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071624ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071624ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071624ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071624ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071624ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071624ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071624ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071624ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071624ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071624ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071625ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071625ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071625ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071625ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071625ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071625ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071625ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071625ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071625ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071625ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071625ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071625ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071625ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071626ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071626ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071626ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071626ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071626ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071626ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071626ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071626ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071626ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071626ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071627ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071627ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071627ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071627ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071627ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071627ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071627ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071627ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071627ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071627ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071628ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071628ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071628ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071628ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071628ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071628ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071628ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071628ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071628ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071628ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071629ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071629ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071629ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071629ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071629ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071629ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071629ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071629ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071629ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071629ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071629ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071629ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071629ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071630ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071630ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071630ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071630ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071630ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071630ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071630ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071630ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071630ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071630ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071630ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071630ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071630ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071631ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071631ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071631ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071631ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071631ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071631ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071631ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071631ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071631ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071631ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071632ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071632ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071632ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071632ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071632ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071632ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071632ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071632ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071632ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071632ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071632ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071632ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071632ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071633ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071633ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071633ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071633ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071633ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071633ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071633ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071633ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071633ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071633ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071634ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071634ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071634ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071634ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071634ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071634ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071634ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071634ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071634ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071634ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071635ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071635ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071635ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071635ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071635ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071635ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071635ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071635ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071635ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071635ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071636ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071636ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071636ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071636ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071636ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071636ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071636ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071636ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071636ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071636ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071638ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071638ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071638ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071638ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071638ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071638ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071638ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071638ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071638ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071638ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071639ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071639ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071639ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071639ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071639ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071639ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071639ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071639ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071639ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071639ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071640ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071640ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071640ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071640ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071640ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071640ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071640ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071640ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071640ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071640ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071640ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071640ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071640ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071641ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071641ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071641ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071641ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071641ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071641ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071641ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071641ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071641ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071641ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071642ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071642ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071642ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071642ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071642ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071642ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071642ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071642ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071642ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071642ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071643ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071643ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071643ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071643ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071643ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071643ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071643ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071643ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071643ECSEQ3ECTDV Temporary Delay of Vaccination Y CRF C4591001ECC4591001 1007 10071643ECSEQ3FDDTC Date of First Delay 2021-05-17 CRF C4591001ECC4591001 1007 10071643ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071643ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071643ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071643ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071644ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071644ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071644ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071644ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071644ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071644ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071644ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071644ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071644ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071644ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071645ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071645ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071645ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071645ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071645ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071645ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071645ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071645ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071645ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071645ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071645ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071645ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071645ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071646ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071646ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071646ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071646ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071646ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071646ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071646ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071646ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071646ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071646ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071646ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071646ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071646ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071647ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071647ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071647ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071647ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071647ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071647ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071647ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071647ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071647ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071647ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071648ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071648ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071648ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071648ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071648ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071648ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071648ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071648ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071648ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071648ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071648ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071648ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071648ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071649ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071649ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071649ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071649ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071649ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071649ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071649ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071649ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071649ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071649ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071650ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071650ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071650ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071650ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071650ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071650ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071650ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071650ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071650ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071650ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071650ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071650ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071650ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071651ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071651ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071651ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071651ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071651ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071651ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071651ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071651ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071651ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071651ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071652ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071652ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071652ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071652ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071652ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071652ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071652ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071652ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071652ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071652ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071652ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071652ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071652ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071653ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071653ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071653ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071653ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071653ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071653ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071653ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071653ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071653ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071653ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071654ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071654ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071654ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071654ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071654ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071654ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071654ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071654ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071654ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071654ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071655ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071655ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071655ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071655ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071655ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071655ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071655ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071655ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071655ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071655ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071655ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071655ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071655ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071656ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071656ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071656ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071656ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071656ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071656ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071656ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071656ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071656ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071656ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071658ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071658ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071658ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071658ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071658ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071658ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071658ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071658ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071658ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071658ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071658ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071658ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071658ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071659ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071659ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071659ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071659ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071659ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071659ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071659ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071659ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071659ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071659ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071660ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071660ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071660ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071660ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071660ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071660ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071660ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071660ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071660ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071660ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071660ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071660ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1007 10071660ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071661ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071661ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071661ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071661ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071661ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071661ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071661ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071661ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071661ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071661ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071662ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071662ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071662ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071662ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071662ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1007 10071662ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071662ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1007 10071662ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1007 10071662ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1007 10071662ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081751ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081751ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081751ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081751ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081751ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081751ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081751ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081751ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081751ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081751ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081751ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081751ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081751ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081752ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081752ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081752ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081752ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081752ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081752ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081752ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081752ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081752ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081752ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081752ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081752ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081752ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081753ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081753ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081753ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081753ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081753ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081753ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081753ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081753ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081753ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081753ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081754ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081754ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081754ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081754ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081754ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081754ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081754ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081754ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081754ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081754ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081755ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081755ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081755ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081755ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081755ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081755ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081755ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081755ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081755ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081755ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081756ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081756ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081756ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081756ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081756ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081756ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081756ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081756ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081756ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081756ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081756ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081756ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081756ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081757ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081757ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081757ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081757ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081757ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081757ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081757ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081757ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081757ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081757ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081757ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081757ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081757ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081758ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081758ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081758ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081758ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081758ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081758ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081758ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081758ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081758ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081758ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081760ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081760ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081760ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081760ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081760ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081760ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081760ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081760ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081760ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081760ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081761ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081761ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081761ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081761ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081761ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081761ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081761ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081761ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081761ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081761ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081761ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081761ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081761ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081763ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081763ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081763ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081763ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081763ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081763ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081763ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081763ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081763ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081763ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081763ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081763ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081763ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081764ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081764ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081764ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081764ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081764ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081764ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081764ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081764ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081764ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081764ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081767ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081767ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081767ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081767ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081767ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081767ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081767ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081767ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081767ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081767ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081767ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081767ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081767ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081768ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081768ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081768ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081768ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081768ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081768ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081768ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081768ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081768ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081768ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081769ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081769ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081769ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081769ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081769ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081769ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081769ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081769ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081769ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081769ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081770ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081770ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081770ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081770ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081770ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081770ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081770ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081770ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081770ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081770ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081771ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081771ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081771ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081771ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081771ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081771ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081771ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081771ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081771ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081771ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081773ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081773ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081773ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081773ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081773ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081773ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081773ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081773ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081773ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081773ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081773ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081773ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081773ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081774ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081774ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081774ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081774ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081774ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081774ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081774ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081774ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081774ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081774ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081775ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081775ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081775ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081775ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081775ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081775ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081775ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081775ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081775ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081775ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081775ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081775ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081775ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081777ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081777ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081777ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081777ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081777ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081777ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081777ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081777ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081777ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081777ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081780ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081780ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081780ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081780ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081780ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081780ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081780ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081780ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081780ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081780ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081780ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081780ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081780ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081781ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081781ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081781ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081781ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081781ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081781ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081781ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081781ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081781ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081781ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081781ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081781ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081781ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081785ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081785ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081785ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081785ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081785ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081785ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081785ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081785ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081785ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081785ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081788ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081788ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081788ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081788ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081788ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081788ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081788ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081788ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081788ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081788ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081788ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081788ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081788ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081789ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081789ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081789ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081789ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081789ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081789ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081789ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081789ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081789ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081789ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081790ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081790ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081790ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081790ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081790ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081790ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081790ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081790ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081790ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081790ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081790ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081790ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081790ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081791ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081791ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081791ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081791ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081791ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081791ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081791ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081791ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081791ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081791ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081792ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081792ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081792ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081792ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081792ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081792ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081792ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081792ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081792ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081792ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081793ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081793ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081793ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081793ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081793ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081793ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081793ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081793ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081793ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081793ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081793ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081793ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081793ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081794ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081794ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081794ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081794ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081794ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081794ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081794ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081794ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081794ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081794ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081794ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081794ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081794ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081795ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081795ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081795ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081795ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081795ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081795ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081795ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081795ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081795ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081795ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081796ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081796ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081796ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081796ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081796ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081796ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081796ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081796ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081796ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081796ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081796ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081796ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081796ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081797ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081797ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081797ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081797ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081797ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081797ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081797ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081797ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081797ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081797ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081798ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081798ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081798ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081798ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081798ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081798ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081798ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081798ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081798ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081798ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081798ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081798ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081798ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081799ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081799ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081799ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081799ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081799ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081799ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081799ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081799ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081799ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081799ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081800ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081800ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081800ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081800ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081800ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081800ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081800ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081800ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081800ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081800ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081801ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081801ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081801ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081801ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081801ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081801ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081801ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081801ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081801ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081801ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081801ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081801ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081801ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081802ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081802ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081802ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081802ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081802ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081802ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081802ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081802ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081802ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081802ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081803ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081803ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081803ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081803ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081803ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081803ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081803ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081803ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081803ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081803ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081803ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081803ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081803ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081804ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081804ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081804ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081804ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081804ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081804ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081804ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081804ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081804ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081804ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081804ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081804ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081804ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081805ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081805ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081805ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081805ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081805ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081805ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081805ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081805ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081805ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081805ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081806ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081806ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081806ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081806ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081806ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081806ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081806ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081806ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081806ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081806ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081807ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081807ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081807ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081807ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081807ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081807ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081807ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081807ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081807ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081807ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081807ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081807ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081807ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081808ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081808ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081808ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081808ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081808ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081808ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081808ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081808ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081808ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081808ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081808ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081808ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081808ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081809ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081809ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081809ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081809ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081809ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081809ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081809ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081809ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081809ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081809ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081809ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081809ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081809ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081810ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081810ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081810ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081810ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081810ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081810ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081810ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081810ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081810ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081810ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081811ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081811ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081811ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081811ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081811ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081811ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081811ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081811ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081811ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081811ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081812ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081812ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081812ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081812ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081812ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081812ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081812ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081812ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081812ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081812ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081812ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081812ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081812ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081813ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081813ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081813ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081813ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081813ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081813ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081813ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081813ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081813ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081813ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081814ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081814ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081814ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081814ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081814ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081814ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081814ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081814ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081814ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081814ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081815ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081815ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081815ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081815ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081815ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081815ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081815ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081815ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081815ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081815ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081815ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081815ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081815ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081816ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081816ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081816ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081816ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081816ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081816ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081816ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081816ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081816ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081816ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081817ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081817ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081817ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081817ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081817ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081817ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081817ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081817ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081817ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081817ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081817ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081817ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081817ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081818ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081818ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081818ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081818ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081818ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081818ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081818ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081818ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081818ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081818ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081819ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081819ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081819ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081819ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081819ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081819ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081819ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081819ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081819ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081819ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081819ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081819ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081819ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081820ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081820ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081820ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081820ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081820ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081820ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081820ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081820ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081820ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081820ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081820ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081820ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081820ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081821ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081821ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081821ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081821ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081821ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081821ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081821ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081821ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081821ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081821ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081822ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081822ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081822ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081822ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081822ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081822ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081822ECSEQ3ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ3ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ3ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081822ECSEQ3ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081822ECSEQ3ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081822ECSEQ4ECCD Standardized Medication Code 15268625001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ4ECDECODStandardized Medication Name TOZINAMERAN ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081822ECSEQ4ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081822ECSEQ4ECOBSVTTimeframe Subject Was Observed 30 MINUTES CRF C4591001ECC4591001 1008 10081822ECSEQ4ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081823ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081823ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081823ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081823ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081823ECSEQ1ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081823ECSEQ2ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081823ECSEQ2ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081823ECSEQ2ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081823ECSEQ2ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081823ECSEQ2ECTDV Temporary Delay of Vaccination N CRF C4591001ECC4591001 1008 10081824ECSEQ1ECCD Standardized Medication Code 90150901001 ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081824ECSEQ1ECDECODStandardized Medication Name BLINDED THERAPY ASSIGNEDCLINICAL STUDY SPONSORC4591001ECC4591001 1008 10081824ECSEQ1ECOBSV Observed Post Dose For Specified TimeY CRF C4591001ECC4591001 1008 10081824ECSEQ1ECOBSVTTimeframe Subject Was Observed THE PROTOCOL SPECIFIED OBSERVATION PERIOD CRF C4591001ECC4591001 1008 10081824ECSEQ1ECTDV Temporary Delay of Vaccination N